- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.73 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.2: 34 residues within 4Å:- Chain A: R.161, G.222, G.223, G.224, T.246, L.247, M.248, M.263, L.264, G.265, M.266, H.267, G.286, V.287, R.288, D.290, R.292, V.293, I.309, D.310, I.311, D.312, E.315, G.328, D.329, V.330, V.400, Q.404, M.405, S.422, G.423, G.424, G.426
- Chain B: F.121
24 PLIP interactions:22 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:V.400, B:F.121
- Hydrogen bonds: A:L.99, A:R.161, A:G.223, A:G.224, A:T.246, A:L.247, A:L.264, A:H.267, A:G.268, A:V.287, A:R.288, A:R.288, A:I.311, A:D.329, A:D.329, A:V.330, A:G.423
- Water bridges: A:S.101, A:R.161, A:R.292
- Salt bridges: A:R.288
- pi-Stacking: B:F.121
FAD.8: 34 residues within 4Å:- Chain A: F.121
- Chain B: R.161, G.222, G.223, G.224, T.246, L.247, M.248, M.263, L.264, G.265, M.266, H.267, G.286, V.287, R.288, D.290, R.292, V.293, I.309, D.310, I.311, D.312, E.315, G.328, D.329, V.330, V.400, Q.404, M.405, S.422, G.423, G.424, G.426
24 PLIP interactions:22 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:V.400, A:F.121
- Hydrogen bonds: B:L.99, B:R.161, B:G.223, B:G.224, B:T.246, B:T.246, B:L.247, B:L.264, B:H.267, B:G.268, B:V.287, B:R.288, B:R.288, B:I.311, B:D.329, B:V.330, B:G.423
- Water bridges: B:S.101, B:R.161, B:R.292
- Salt bridges: B:R.288
- pi-Stacking: A:F.121
- 2 x 6R5: methyl 4-[(3-methoxy-4-methyl-5-oxidanylidene-1,2,4-triazol-1-yl)carbonylsulfamoyl]-5-methyl-thiophene-3-carboxylate(Non-covalent)
6R5.3: 12 residues within 4Å:- Chain A: D.291, R.292, W.489, S.568
- Chain B: G.36, A.37, V.111, P.112, M.115, F.121, Q.122, K.171
8 PLIP interactions:3 interactions with chain B, 5 interactions with chain A- Hydrogen bonds: B:K.171, B:K.171, A:R.292, A:R.292, A:S.568
- Salt bridges: B:K.171
- pi-Stacking: A:W.489
- pi-Cation interactions: A:R.292
6R5.9: 12 residues within 4Å:- Chain A: G.36, A.37, V.111, P.112, M.115, F.121, Q.122, K.171
- Chain B: D.291, R.292, W.489, S.568
8 PLIP interactions:3 interactions with chain A, 5 interactions with chain B- Hydrogen bonds: A:K.171, A:K.171, B:R.292, B:R.292, B:S.568
- Salt bridges: A:K.171
- pi-Stacking: B:W.489
- pi-Cation interactions: B:R.292
- 2 x NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID(Non-covalent)
NHE.4: 6 residues within 4Å:- Chain A: K.135, H.136, L.188, P.189, G.190, Y.191
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:H.136, A:L.188, A:G.190, A:Y.191
- Water bridges: A:R.194
NHE.10: 6 residues within 4Å:- Chain B: K.135, H.136, L.188, P.189, G.190, Y.191
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:H.136, B:L.188, B:G.190, B:Y.191
- Water bridges: B:R.194
- 2 x K: POTASSIUM ION(Non-covalent)
K.5: 7 residues within 4Å:- Chain A: M.458, N.459, Q.461
- Chain B: M.458, N.459, Q.461
- Ligands: K.11
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain A- Metal complexes: B:M.458, A:M.458
K.11: 7 residues within 4Å:- Chain A: M.458, N.459, Q.461
- Chain B: M.458, N.459, Q.461
- Ligands: K.5
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain A- Metal complexes: B:M.458, A:M.458
- 2 x TZD: 2-{3-[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]-4-METHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOL-5-YL}ETHYL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
TZD.6: 26 residues within 4Å:- Chain A: V.400, G.401, Q.402, H.403, G.426, M.428, G.452, D.453, G.454, S.455, M.458, N.480, H.482, L.483, G.484, M.485, V.486
- Chain B: Y.33, P.34, G.35, E.59, T.82, P.85, N.89, Q.122
- Ligands: MG.1
20 PLIP interactions:18 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:M.428, A:L.483, A:L.483, A:V.486, B:Y.33
- Hydrogen bonds: A:Q.402, A:H.403, A:G.426, A:M.428, A:G.454, A:S.455, A:N.480, A:H.482, A:G.484, A:M.485, B:Q.122
- Water bridges: A:D.453, A:D.453
- Salt bridges: A:H.403, A:H.403
TZD.12: 26 residues within 4Å:- Chain A: Y.33, P.34, G.35, E.59, T.82, P.85, N.89, Q.122
- Chain B: V.400, G.401, Q.402, H.403, G.426, M.428, G.452, D.453, G.454, S.455, M.458, N.480, H.482, L.483, G.484, M.485, V.486
- Ligands: MG.7
19 PLIP interactions:2 interactions with chain A, 17 interactions with chain B- Hydrophobic interactions: A:Y.33, B:M.428, B:L.483, B:L.483, B:V.486
- Hydrogen bonds: A:Q.122, B:Q.402, B:H.403, B:G.426, B:M.428, B:G.454, B:S.455, B:H.482, B:G.484, B:M.485
- Water bridges: B:D.453, B:D.453
- Salt bridges: B:H.403, B:H.403
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Garcia, M.D. et al., Comprehensive understanding of acetohydroxyacid synthase inhibition by different herbicide families. Proc. Natl. Acad. Sci. U.S.A. (2017)
- Release Date
- 2017-02-08
- Peptides
- Acetolactate synthase, chloroplastic: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.73 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x 6R5: methyl 4-[(3-methoxy-4-methyl-5-oxidanylidene-1,2,4-triazol-1-yl)carbonylsulfamoyl]-5-methyl-thiophene-3-carboxylate(Non-covalent)
- 2 x NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID(Non-covalent)
- 2 x K: POTASSIUM ION(Non-covalent)
- 2 x TZD: 2-{3-[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]-4-METHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOL-5-YL}ETHYL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Garcia, M.D. et al., Comprehensive understanding of acetohydroxyacid synthase inhibition by different herbicide families. Proc. Natl. Acad. Sci. U.S.A. (2017)
- Release Date
- 2017-02-08
- Peptides
- Acetolactate synthase, chloroplastic: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A